Generalized Bullous Fixed Drug Eruption due to Clopidogrel Hypersensitivity Successfully Treated Using the Jefferson Procedure
- 11 May 2026
- journal article
- case report
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 53 (10) , 937-940
Abstract
Generalized bullous fixed drug eruption (GBFDE) is a rare variant of fixed drug eruption that is known to clinically mimic Stevens‐Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). Numerous medications have been reported to cause GBFDE, including antiplatelet agents like ticagrelor, but few reports exist linking this reaction to clopidogrel specifically. We report a case of a medically complex 80‐year‐old male who was found to have clopidogrel hypersensitivity manifesting as GBFDE based on clinical characteristics and pathology. He was successfully treated using the Jefferson desensitization protocol, which was developed by cardiologists to enable continuation of clopidogrel. While clopidogrel hypersensitivity reactions are well‐reported, there is a shortage of dermatology literature characterizing the clinical characteristics of these rashes and highlighting the use of the Jefferson desensitization protocol. This case reports on an etiology for GBFDE that is rarely observed and emphasizes the importance of histopathology when differentiating this entity from SJS/TEN. It also reports the successful use of the Jefferson protocol for GBFDE secondary to clopidogrel hypersensitivity.Keywords
This publication has 12 references indexed in Scilit:
- A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug EruptionMedicina, 2021
- Successful desensitization to metronidazole in a patient with generalized fixed drug eruptionThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Treatment of Clopidogrel Hypersensitivity: The Jefferson ApproachCurrent Vascular Pharmacology, 2019
- Management of Antiplatelet Allergy After Cardiac StentingJAMA Dermatology, 2016
- Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological featuresJournal of the American Academy of Dermatology, 2014
- Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysisBritish Journal of Dermatology, 2013
- Fixed-drug eruption: A retrospective study in a single referral center in northern TaiwanDermatologica Sinica, 2012
- Clopidogrel hypersensitivity: clinical challenges and options for managementExpert Review of Clinical Pharmacology, 2010
- Frequency of Allergic or Hematologic Adverse Reactions to Ticlopidine Among Patients With Allergic or Hematologic Adverse Reactions to ClopidogrelCirculation: Cardiovascular Interventions, 2009
- Successful Desensitization to Fixed Drug Eruption: The Presence of CD25+CD4+ T Cells in the Epidermis of Fixed Drug Eruption Lesions May Be Involved in the Induction of DesensitizationDermatology, 2004